Page 63 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon
P. 63

1522_C01.fm  Page 50  Tuesday, December 2, 2003  10:05 AM









                              182. Martinez, M., Mercado, O., Santamaria, A., Galvan, S., Vazquez, M., Bucio,
                                   V., Hall, C., Hernandez, R., Hurtazo, A., Pego, E., Rodriguez, F., Salvatierra,
                                   R., Sosa, A., and Rios, C., The action of amfepramone on neurochemical and
                                   behavioral markers in rats, Proc. West. Pharmacol. Soc., 41, 125, 1998.
                              183. Glennon, R.A., Yousif, M., Naiman, N., and Kalix, P., Methcathinone: a new
                                   and potent amphetamine-like agent,  Pharmacol. Biochem. Behav., 26, 547,
                                   1987.
                              184. Kalix, P. and Glennon, R.A., Further evidence for an amphetamine-like mech-
                                   anism of action of the alkaloid cathinone, Biochem. Pharmacol., 35, 3015, 1986.
                              185. Bryant, S.G., Guernsey, B.G., and Ingrim, N.B., Review of bupropion, Clin.
                                   Pharm., 2, 525, 1983.
                              186. Springer, D., Peters, F.T., Fritschi, G., and Maurer, H.H., GC-MS studies on
                                   the metabolism and toxicological analysis of the new pyrrolidino-hexanophe-
                                   none designer drug 4¢-methyl-alpha-pyrrolidinohexanophenone (MPHP), in
                                   Proceedings of the 40th International TIAFT Meeting in Paris, Marquet, P., Ed.,
                                   TIAFT, Strasbourg, France, 2003.
                              187. Springer, D., Paul, L.D., Staack, R.F., Kraemer, T., and Maurer, H.H., Identi-
                                   fication of the cytochrome P450 enzymes involved in the metabolism of 4¢-
                                   methyl-pyrrolidinopropiophenone (MPPP),  a novel scheduled designer
                                   drug, in human liver microsomes, Drug Metab. Dispos., 31, 979, 2003.
                              188. Springer, D., Fritschi, G., and Maurer, H.H., Metabolism and toxicological
                                   detection of the new designer drug 4¢-methoxy-alpha-pyrrolidinopropiophe-
                                   none (MOPPP) studied in urine using gas chromatography-mass spectrom-
                                   etry, J. Chromatogr. B, submitted, 2003.
                              189. de Kanel, J., Vickery, W.E., Waldner, B., Monahan, R.M., and Diamond, F.X.,
                                   Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-
                                   LSD from blood, serum, plasma, and urine samples using the Zymark
                                   RapidTrace with LC/MS/MS confirmation, J. Forensic Sci., 43, 622, 1998.
                              190. Hoja, H., Marquet, P., Verneuil, B., Lotfi, H., Dupuy, J.L., and Lachatre, G.,
                                   Determination of LSD and N-demethyl-LSD in urine by liquid chromatog-
                                   raphy coupled to electrospray ionization mass spectrometry, J. Chromatogr.
                                   B, 692, 329, 1997.
                              191. Cai, J. and Henion, J., Elucidation of LSD  in vitro  metabolism by liquid
                                   chromatography and capillary electrophoresis coupled with tandem mass
                                   spectrometry, J. Anal. Toxicol., 20, 27, 1996.
                              192. Stout, P.R., Horn, C.K., and Klette, K.-L., Solid-phase extraction and GC-MS
                                   analysis of THC-COOH method optimized for a high-throughput forensic
                                   drug-testing laboratory, J. Anal. Toxicol., 25, 550, 2001.
                              193. ElSohly, M.A., deWit, H., Wachtel, S.R., Feng, S., and Murphy, T.P., Delta 9-
                                   tetrahydrocannabivarin as a marker for the ingestion of marijuana versus
                                   Marinol: results of a clinical study, J. Anal. Toxicol., 25, 565, 2001.




                             © 2004 by CRC Press LLC
   58   59   60   61   62   63   64   65   66   67   68